Comparison of clinical stage, therapy response, and patient outcome between squamous cell carcinoma and adenocarcinoma of the esophagus

International Journal of Gastrointestinal Cancer

Volumn 36, Issue 2, 2005, Pages 69-76

  Rohatgi, Pooja R ^a   Swisher, Stephen G ^a   Correa, Arlene M ^a   Wu, Tsung T ^a   Liao, Zhongxing ^a   Walsh, Garrett L ^a   Vaporciyan, Ara A ^a   Rice, David C ^a   Fukami, Norio ^a   Roth, Jack A ^a   Ajani, Jaffer A ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b Department of Gastrointestinal Medical Oncology ^*  (United States)

Author keywords

Adenocarcinoma of esophagus; Chemoradiotherapy; Pathologic response; Squamous cell carcinoma of esophagus

Indexed keywords

CAMPTOTHECIN; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; DISEASE COURSE; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; RECURRENCE; SEX DISTRIBUTION; TEXAS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33745760607     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/IJGC:36:2:69     Document Type: Article

References (16)

1. Posner MC, Gooding WE, Landreneau RJ, et al. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am 1998;4(4):237-246.
2. Jones DR, Detterbeck FC, Egan TM, et al. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Soc Thoracic Surg 1997;64:185-192.
3. Forastiere AA, Orringer MB, Perez-Tamayo C, et al. Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 1990;8(1):119-127.
4. De Vita F, Martino ND, Orditura M, et al. Preoperative chemoradiotherapy for squamous cell carcinoma and adenocarcinoma of the esophagus. Chest 2002;122:1302-1308.
5. Makary MA, Kiernan PD, Sheridan MJ, et al. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy. Am Surg 2003;69:693-702.
6. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000;18(4):868-876.
7. Lew JI, Gooding WE, Ribeiro U Jr, et al. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg 2001;136(7):737-743.
8. Forastiere AA, Heitmiller RF, Lee DJ, et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am 1997;3(3):144-152.
9. Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996;14(3):829-837.
10. Meneu-Diaz JC, Blazquez LA, Vicente E, et al. The role of multimodality therapy for resectable esophageal cancer. Am J Surg 2000;179:508-513.
11. Slater MS, Holland J, Faigel DO, et al. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001;181:440-444.
12. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th Ed. Springer, New York, NY; 2002; pp. 91-98.
13. Kalha I, Kaw M, Fukami, N, et al. The accuracy of endoscopic ultrasound for restaging esophagel carcinoma after chemoradiation therapy. Cancer 2004;101(5):940-947.
14. Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 2005;103(7):1347-1355.
15. Kitajima M, Kitagawa Y. Surgical treatment of esophageal cancer - the advent of the era of individualizaiton. N Engl J Med 2002;347:1705-1709.
16. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347:1662-1669.